About the authors

From the following article:

Drug-eluting stent pathology—should we still be cautious?

Gaku Nakazawa, Aloke V Finn and Renu Virmani

Nature Clinical Practice Cardiovascular Medicine (2008) 5, 1
doi:10.1038/ncpcardio1093

BACK TO ARTICLE

Gaku Nakazawa

 

G Nakazawa is a Cardiovascular Fellow at the CVPath Institute, Gaithersburg, MD, USA.

Aloke V Finn

 

AV Finn is Assistant Professor in the Division of Cardiology at the Emory University School of Medicine in Atlanta, GA, USA. His research interests include coronary plaque progression and vascular response to stent injury.

Renu Virmani

 

R Virmani is Medical Director of the CVPath Institute, Gaithersburg, MD, USA—a private nonprofit organization—and a cardiovascular pathologist. Her main areas of research interest are in the pathology of human atherosclerotic plaques and the vascular biology underlying plaque progression and in stent-induced vascular injury in humans and in animals. She is an Advisory Board member of Nature Clinical Practice Cardiovascular Medicine.

BACK TO ARTICLE